Peru declared a 90-day state of emergency on Saturday after an “unusual increase” in Guillain-Barre syndrome.
Guillain-Barre syndrome is a rare disease in which the immune system attacks a part of the nervous system.
The Gateway Pundit has reported on Increased Guillain-Barre Syndrome following the introduction of the COVID vaccine.
Scientists recommend that elderly people who received Pfizer’s RSV vaccine should be monitored for Guillain-Barre syndrome.
This comes after two adults who were shot in clinical trials developed Guillain-Barre syndrome, scientists said in clinical results published in the New England Journal of Medicine on CNBC.
“If the RSVpreF vaccine is approved and approved, these adverse events should be carefully evaluated in future studies and with international data and post-marketing surveillance,” the scientists wrote. The study, published Wednesday, was sponsored by Pfizer.
And a 40-year-old British man was be given compensation after being diagnosed with Guillain-Barre disease.
The Sun Daily he said:
Peru’s government declared a 90-day state of emergency on Saturday due to an “unusual increase” in Guillain-Barre disease, which has resulted in 165 deaths and four deaths, Xinhua reported.
The law, which was published in the newspaper El Peruano, describes the plan made with a budget of 12.12 million soles (US $ 3.3 million) with the aim of improving the care of patients in hospitals, promoting the management of cases and preparing informative articles. for people and health.
Among them were the acquisition of intravenous immunoglobulin and human albumin, as well as the special investigation of pathogens associated with the disease and the support of ventilation in emergency or critical patients.
Guillain-Barre syndrome is a rare disease in which the immune system attacks part of the peripheral nervous system.
So far this year, about 18 of the 24 departments in the country have reported at least one case of the disease.